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INTRODUCTION
assisted thoracoscopic surgery have decreased the morbidity of lung biopsy. [7] [8] [9] Nevertheless, lung biopsy A child who presents with severe respiratory distress is still an invasive procedure associated with with diffuse infiltrates seen on the chest radiograph is significant morbidity and mortality, especially in often a diagnostic challenge. Empirical therapy is immunocompromised children. radiologic findings, definitive diagnosis is required. Less invasive procedures such as bronchoscopy and broncho alveolar lavage may be helpful in diagnosing infectious causes, [1] but not so in noninfectious causes and in some fungal infections, when a lung biopsy may be essential. Lung biopsy is considered to be the gold standard for the diagnosis of parenchymal lung disease.
[2-5] Recent advances in imaging techniques viz, high resolution computerized tomography have helped in accurate localization of pulmonary lesions. [6] The improvements in pediatric anesthesia and the emergence of videoOur aim of this review is to evaluate the yield of lung biopsy done at King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia (KFSH and RC), to make a specific diagnosis in both immunocompetent and immunocompromised child, whether open lung biopsy (OLB) resulted in change in therapy, to assess morbidity and mortality of the procedure and develops strategies or find alternative to OLB.7
MATERIALS AND METHODS
A retrospective review of 91 lung biopsies in 83 children was performed at KFSH and RC, with the age range between 3 months to 15 years (median = 7.37 years), The trend later was to remove the chest tube after reexpansion of the lung on table with positive pressure ventilation, except when there was a risk of persistent air-leak/bleeding from the biopsy site and in ventilated patients.
The biopsy tissue was subjected to regular histopathology, including special studies for acid-fast bacilli; fungus; cytomegalovirus (CMV); pneumocystis carinii and also the specific cultures. Change in therapy was instituted when indicated, based on the pathological/ culture results; and the outcome (benefit or otherwise) was analyzed. underlying immunodeficiency or malignancy. Indication for OLB in this group primarily prolonged respiratory RESULTS distress with significant radiological abnormalities with or without oxygen dependency.
In Group I, histological specific diagnosis reached in 21 (95%) with 10 (45%) unexpected diagnosis [ Table 1 ]. Group II are those congenital primary immunodeficiency However, change in therapy as a result of OLB was in 11 common variable ID (2), bore lymphocytic syndrome (2), (50%). Two had Nissen fundoplication for lipoid severe combined ID (scid) (3), chronic granulometous pneumonia [ Figure 1 ], Secondary to GER, one lobectomy, disease, Chediak Higashi syndrome (1).
five steroid therapy for hemosiderosis [ Figure 2 ] and sarcoidosis, two anti-tuberculous treatments and one The primary indication of OLB in this group is recurrent septra and choriquine for streptomyces. chest infection with persistent or worsening radiological For Group II a, specific histological diagnosis reached in 10 (100%) and tissue culture was positive in only five Group II b, are those children who was on chemotherapy (50%) (bacterial-1; mycobacterial-1 [ Figure 3 ]; fungal-1; and those postbonemarrow transplant (BMT): AML (12), a mixed growth of all three-1 and pneumocystis carinii-ALL (16), lymphoma (2) and post BMT (9) . Those patients usually had routine computed tomography (CT) scan of chest if they develop fever or chest symptoms or shows Group III (20) those patient suggestive of pulmonary metastatic lesion to solid tumor. Both Group I and II patients started first on emperic treatment before OLB, in the form of antibiotic, antifungal or steroids according to prebiopsy clinical and radiological diagnosis. Group III, all sent for biopsy based on suspecting metastatic lesion radiologically, either persistent lesions despite chemotherapy or lesions appeared during remission of solid tumors. These lesions should be three or less, to quality for OLB.
The lung biopsy was performed under general anesthesia by thoracotomy (open lung biopsy -OLB) or by videoassisted thoracoscopic surgery. OLB was performed by a muscle-sparing mini-thoracotomy (n=56) through the 4 th / 5 th intercostals space. Thoracoscopic biopsy (n=28) was performed by using three ports -a 5/10 mm port for a 30 o telescope and two other 3.5/5 mm working ports, with (n=7) converted to open. Biopsy was taken using an endo-GIA stapler or rarely with an endo-loop. A chest tube was left in situ for 24 hours in the initial cases.
Al-Nassar S, et al.: Value of lung biopsy in pulmonary disease in children bronchopleural fistula (1) and septic shock in one, but procedure-related morbidity 3/91 (3.2%). Mortality was six (6.5%) (within 1 month), with only one (1.1%) procedure-related.
DISCUSSION
The causes of persistent and progressive distress in a child are many including interstitial lung disease, infections, chronic aspiration, pulmonary vascular disease, and other rare conditions. A specific diagnosis can frequently be made from the chest X-ray or CT scan appearance of the lung lesions and the appropriate therapy started. This may not be true in children occasionally, where the appearances on the imaging studies are nonspecific. [13] patients who have been started on empiric therapy, but are not responding to this type of treatment where there is in need for other mode of diagnostic tools.
Children postchemotherapy particularly for leukemia and lymphomas and also those children who are postbone marrow transplant as well as other immunocompromised children like primary and secondary immunodeficiency, are at risk of developing a serious pulmonary complications. These children usually have severe and prolonged neutropenia and they will be at risk of There is also a group of specific antifungal, Each one antiviral and prolonged antibiotic).
In Group III, 13 (65%) were positive for metastatic lesion to solid tumor, five (25%) has infectious process and two (10%) negative explorations. So, Specific diagnosis reached in 18 (90%) [ Table 2 ].
The overall specific histological diagnosis reached in 87/ 91 (95%) but change in therapy "excluding lung metastasis" 23/71 (32%). Tissue culture was positive in only 17/91 (18.7%) [ Table 2 ].
Our morbidity was 11 children (12.1%), prolonged intubation (6), oxygen dependency (2), hematoma (1), developing opportunistic infections. With the widespread use of prophylactic antibiotics, antiviral drugs for CMV and Septran ® for pneumocystis carinii, there has been a significant decrease in the incidence of these infections as well as of their complications. Some centers even advocate the empiric use of antifungal therapy in the group of neutropenic patients with persistent fever and characteristic lesions of lung infection on CT scans. An optimal and safe means of obtaining lung tissue for diagnosis is debatable, but an open lung biopsy either by thoracotomy or thoracoscopy can be considered to be the best diagnostic tool.
[2-5] We found, in our group of patients, it is safe and provide good volume of tissue for diagnostic purposes. Video-assisted thoracoscopic surgery provides a better and wider visibility of the lung surface, with less morbidity than the mini-thoracotomy. Also with the availability of finer instruments, VATS is now feasible even in the smaller group of children. We find that it is safe despite reports of high morbidity and mortality in other studies.
The main issue when considering a lung biopsy is whether or not there is a practical benefit from the invasive procedure with its associated morbidity and mortality. This is especially true in sicker children with immunosuppression from chemotherapy/postBMT where the benefits should be weighed with the risks developed. We found that it is a good tool to reach a morbidity and mortality compared to other series. We still continue to use lung biopsy as a tool for the purpose of diagnosing pulmonary infiltrate as it benefits around 30% of the patients in regard to change of therapy, however, it benefit the rest of the group in continuing using the same management and has given comfort to the treating physician to continue the same line of management.
CONCLUSION
We wish to reiterate that lung biopsy is a sensitive diagnostic tool to reach specific histological diagnosis specific diagnosis and this is similar to other reports (95%). However, it is only helpful in (32%) to make from other groups, but it is not as high when it comes to change in therapy. Change in therapy is less likely in having a positive tissue culture. For that reason, specific those postchemotherapy and BMT, as yield in tissue change in therapy was not high as well. Floreani et al. culture, is lower compare to the rest of the group. Our have collected 14 reports of 625 patients where the total morbidity and mortality are low and considered to be yield in immunocompromised patients was found to be safe in our institution as procedure-related morbidity ranging between 45-83%, however, when it comes to (3.2%) and mortality (1.1%). OLB still considered change in therapy, only 32% which conclude that lung diagnostic and therapeutic in suspected lung metastasis. biopsy can only benefit as high as 30% in Earlier lung biopsy in the course of the disease may be immunocompromised children.
[10] However, Kramer et considered before starting an empiric treatment al reported 46% change in therapy but mortality was as (antibiotic) to get higher tissue culture positive results. high as 39% for immunocompromised children.
[2] HayesJordan et al. has reported 63% survival.
[4] But, these REFERENCES obviously are not procedure-related mortality. However, when we compared it to our overall morbidity was 12.1% 1. McKenna RJ Jr, Campbell A, McMurtrey MJ, Mountain CF and overall mortality was 6.5%, but procedure related Diagnosis for interstitial lung disease in patients with acquired morbidity and mortality was 3.2% and 1.1% respectively. This may be partly due to the fact that these children 2. Kramer MR, Berkman N, Mintz B, Godfrey S, Saute M, Amir with persistent and severe neutropenia are empirically specific diagnosis and giving more comfort to continue 5. Coren ME, Nicholson AG, Goldstraw P, Rosenthal M, Bush A.
. bone marrow in treating the infection, particularly when it comes to fungal infection especially Aspergillosis, which carry high morbidity and mortality if not treated properly. [14, 15] It was also noted in our patient group that the higher morbidity and mortality of patient with those immunocompromised patients.
We think from our results, it may be helpful if the lung biopsy was done early in the course of disease before embarking on starting empiric therapy, which we think that it has contributed to low tissue culture result. As we usually tend to be keen in doing our lung biopsy earlier in the course of disease before serious deterioration of clinical condition contributed to a lower ) .
